CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

New at CADTH - March 2021

Last updated: March 12, 2021
Product Line: New at CADTH
Result type: Report

News and Events

Call for Nominations

CADTH is seeking nominations to its Board of Directors and Expert committees. We’re looking for 15 individuals with significant expertise in the Canadian health care system to join various committees. More information about the roles, the nomination process, honorarium, and time commitments is available here.

Tuberculosis Day Event

To mark World Tuberculosis (TB) Day on March 24, CADTH is hosting an Evidence-to-Action event to discuss TB and the efforts to eradicate this disease in Canada and internationally. WHO estimates that about 10 million people develop TB disease each year and close to 1.4 million die from it. Join this important discussion and hear from our speakers:

  • Dr. Dennis Falzon, Team Lead, Global TB Programme at the World Health Organization, Geneva, Switzerland
  • Caroline Newberry, Public Health and Communicable Disease Specialist, Government of Northwest Territories
  • Dr. Gino De Angelis, Manager, Clinical Research, Medical Devices, CADTH

Ensuring High-Value Health Care After the Pandemic

CADTH is partnering with Choosing Wisely Canada to identify actions that could lead to better post-pandemic care for Canadians. The organizations are developing recommendations for reducing low-value care that, if implemented, could make more resources available to deliver the priority services that are most beneficial to patients. The recommendations will be presented at Choosing Wisely Canada’s National Meeting in May 2021 and will be published in CADTH’s Canadian Journal of Health TechnologiesLearn more.

CADTH’s First Provisional Funding Algorithm

On February 25, CADTH issued our first provisional funding algorithm — a form of expert advice that supports provincial and territorial drug programs and cancer agencies in implementing our cancer drug reimbursement recommendations. Learn more on how provisional funding algorithms offer additional support for the implementation of oncology drug reimbursement recommendations.

NPC Podcast Episode with Suzanne McGurn

Suzanne McGurn, President and CEO of CADTH, is the featured guest on a new episode of The NPC Podcast (S03, E03). She talks with host Peter Brenders about taking the reins at CADTH, how the pandemic has affected CADTH’s work, and the evolving evidence landscape.

CADTH Virtual Symposium Workshops 2020–2021

  • There’s still time to register for our last symposium workshop.
  • The final workshop on March 17, 2021 has been created for policy-makers: Reducing Uncertainty: The Need for Qualitative Research in Evidence-Informed Decision-Making.
  • Participants will become familiar with qualitative research principles, common methods used, and when and how qualitative research can be practically used to influence health policy and practice.
  • Attendance is limited for all workshops, so register to hold your spot.

Want to learn more about our work on COVID-19? Visit our CADTH COVID Evidence Portal.

CADTH Reimbursement Reviews

CADTH recently issued the following reimbursement recommendations:

CADTH Health Technology Reviews

CADTH recently published the following health technology reviews:

CADTH Reference Lists

CADTH recently completed the following reference lists:

Tell Us What You Think

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.